Regulations.gov document
Determination of Regulatory Review Period for Purposes of Patent Extension; PROGENSA PCA3…
Notice · FDA-2012-E-0851 · posted May 30, 2014
Key facts
| Document ID | FDA-2012-E-0851-0007 |
|---|---|
| Title | Determination of Regulatory Review Period for Purposes of Patent Extension; PROGENSA PCA3 ASSAY |
| Document type | Notice |
| Subtype | General Notice |
| Agency | FDA |
| Docket | FDA-2012-E-0851 |
| Posted | May 30, 2014 |
| Federal Register citation | 79 FR 31119 |
| FR document number | 2014-12562 |
| Comment period opens | May 30, 2014 |
| Comments due | Jul 30, 2014 |
| Effective date | May 30, 2014 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: